Showing results (2661-2670 of 3,166) with videos related to

Sort By:
Pageof 317
Neuro-Oncology|February 17, 2010
Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?Carole Ramirez, Clive Bowman, Claude-Alain Maurage, et al.
Neuro-Oncology|February 20, 2010
Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysisJ Lee Villano, Irim Y Virk, Vanessa Ramirez, et al.
Neuro-Oncology|February 20, 2010
Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortexMarjolein de Groot, Sjoukje T Toering, Karin Boer, et al.
Neuro-Oncology|February 20, 2010
Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastomaDoo-Sik Kong, Jung-Il Lee, Jong Hyun Kim, et al.
Neuro-Oncology|September 25, 2016
Tumor treating fields: a novel treatment modality and its use in brain tumorsAndreas F Hottinger, Patricia Pacheco, Roger Stupp
Neuro-Oncology|May 26, 2017
Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer's diseaseSadhana Jackson, Ayman ElAli, Daniela Virgintino, et al.
Neuro-Oncology|June 3, 2017
Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptorXiuping Zhou, Shao Xie, Shishuang Wu, et al.
Neuro-Oncology|March 13, 2010
Activation of the Hedgehog pathway in pilocytic astrocytomasSarah Z Rush, Ty W Abel, Juan G Valadez, et al.
Neuro-Oncology|May 23, 2017
Diagnostic challenges in meningiomaMartha Nowosielski, Norbert Galldiks, Sarah Iglseder, et al.
Neuro-Oncology|May 23, 2017
Correlation of immune phenotype with IDH mutation in diffuse gliomaAnna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, et al.
Pageof 317